Insulin and Insulin-Like Growth Factor I Regulate the Same Biological Functions in HEP-G2 Cells Via Their Own Specific Receptors*
- 1 July 1988
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 67 (1) , 169-174
- https://doi.org/10.1210/jcem-67-1-169
Abstract
The receptors for insulin and insulin-like growth factor I (IGF-I) are closely related molecules, with an extracellular binding domain and an intracellular tyrosine kinase domain. The interaction of insulin and IGF-I with their respective receptors activates the receptor kinase domain, leading to the biological actions of the hormones. Since insulin generally regulates metabolic events and IGF-I generally regulates growth events, it is believed that structural differences in the tyrosine kinase domains of the two respective receptors may elicit different biological responses via different transmembrane signaling mechanisms. We studied the regulation of glycogen metabolism and amino acid uptake in human cultured HEP-G2 hepatoma cells, which have distinct receptors for both insulin and IGF-I. The receptor specificity of these responses was probed with specific monoclonal antibodies to both the insulin and IGFI receptors. Stimulation of both [3H] glucose incorporation into glycogen and α-[3H]aminoisobutyric acid uptake by insulin was half-maximal at concentrations of 1–5 nmol/L. These effects were blocked by the insulin receptor monoclonal antibody MA- 10, but not by the IGF-I receptor antibody aIR-3. Stimulation of both functions by IGF-I was half-maximal at concentrations of 1–5 nmol/L, and these effects were inhibited by aIR-3, but not by MA-10. These studies indicate that in HEP-G2 cells both insulin and IGF-I, via their own receptors, stimulate the same biological responsesKeywords
This publication has 16 references indexed in Scilit:
- Dual regulation of glycogen metabolism by insulin and insulin-like growth factors in human hepatoma cells (HEP-G2). Analysis with an anti-receptor monoclonal antibody.Journal of Clinical Investigation, 1984
- Monoclonal antibodies to receptors for insulin and somatomedin-C.Journal of Biological Chemistry, 1983
- Monoclonal antibodies to the human insulin receptor block insulin binding and inhibit insulin action.Proceedings of the National Academy of Sciences, 1982
- The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor.Journal of Biological Chemistry, 1982
- Interactions of Insulin-Like Growth Factors I and II and Multiplication-Stimulating Activity with Receptors and Serum Carrier ProteinsEndocrinology, 1980
- Direct Demonstration of Separate Receptors for Growth and Metabolic Activities of Insulin and Multiplication-stimulating Activity (an Insulinlike Growth Factor) Using Antibodies to the Insulin ReceptorJournal of Clinical Investigation, 1980
- Insulin‐Like Growth Factors I and II: Some Biological Actions and Receptor Binding Characteristics of Two Purified Constituents of Nonsuppressible Insulin‐Like Activity of Human SerumEuropean Journal of Biochemistry, 1978
- The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin.Journal of Biological Chemistry, 1978
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- Binding of insulin to isolated nuclei.Proceedings of the National Academy of Sciences, 1976